New eye implant could slow vision loss from dry AMD
NCT ID NCT07668804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a biodegradable eye implant called TO-O-1007 for geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The implant slowly releases medication over 6 months to slow disease progression. About 31 adults aged 50 and older will receive either a low-dose, high-dose, or sham injection to evaluate safety and early effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TO-O-1007 implant
What this could lead to
If successful, this could lead to a treatment that slows vision loss from geographic atrophy with fewer injections.
What could go wrong
This is an early phase trial with only 31 people, so safety and effectiveness are not yet proven. The implant may not slow disease progression or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Launceston Eye Doctors
RECRUITINGLaunceston, Tasmania (tas), 7250, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina & Eye Consultants
RECRUITINGHurstville, New South Wales (nsw), 2220, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sydney Retina Clinic & Day Surgery
RECRUITINGSydney, New South Wales (nsw), 2000, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••